CHITOSE Group is a family of biotechnology companies leading the global bioeconomy. To live in abundance beyond the next millennium using the ability of living things, CHITOSE pursues the possibilities of biotechnology through technological and business development collaborating with its business partners all over the world.

Head office that oversees entire Group

Head of Technological Development
and Business Development
as the core corporation of the group
Chitose Laboratory Corp.

  • Microorganism Unit
  • Algae Unit
  • Cell Line Unit
  • Microbiota Unit

Individual companies
that operate separate businesses
Business entities

Implementing and commercializing the results of Chitose Laboratory through business entities

All Business Entities

Head office that oversees entire Group

  • Location
    • Head office: 6 Eu Tong Sen Street #10-12 The Central , Singapore 059817 GOOGLE MAP
    • Japan office: KSP R&D C432, 3-2-1, Sakado, Takatsu-ku, Kawasaki, Kanagawa 213-0012, Japan GOOGLE MAP
  • Business Description Formulating a strategic direction, operating business and financing projects in bio business fields, technological development, business development, financial planning and management, human resource management, and marketing to create business using biotechnology.
  • Directors
    Tomohiro Fujita Ph.D. / Chief Executive Officer Rie Kugimiya / Chief Operating Officer Masayuki Imai / Chief Financial Officer
    management team
  • Advisory board An organization that provides advice and support to directors in charge of management from outside perspectives in order to enhance CHITOSE's corporate value.
    Hiroyuki Suematsu /Former Vice-Minister of Agriculture, Forestry and Fisheries bureaucracy, at present a specially appointed professor at the Tokyo University of Agriculture Research Institute and visiting professor at the Institute for Future Initiatives of the University of Tokyo. Yoshiaki Fujimori /Former Senior Vice Pesident of GE /Former President and CEO of LIXIL Group Corporation , Outside Director of Takeda Pharmaceutical Company Limited, Outside Director of Boston Scientific Corporation, Chairman of the Board of Oracle Corporation Japan, and Senior Executive Advisor to CVC Capital Partners Japan.
    advisory board members
  • Shareholders Tomohiro Fujita 53.6%
    Individuals 35.1%
    Strategic Partners(IHI, ENEOS, Shiseido, NGK, etc.) 11.4%

Head of Technological Development and Business Development

  • Company name Chitose Laboratory Corporationview more
  • Location
    • Nogawa Laboratory (Head office):2-13-3, Nogawahoncho, Miyamae-ku, Kawasaki, Kanagawa 216-0041, Japan GOOGLE MAP
    • KSP Laboratory:KSP R&D C432, 3-2-1, Sakado, Takatsu-ku, Kawasaki, Kanagawa 213-0012, Japan GOOGLE MAP
  • Business Description We have been breeding and cultivating technology for a wide range of organisms (microorganisms, cell lines, microalgae etc) and utilize these technologies for industrial use of the organisms. In addition, in cooperation with the subsidiary companies, we conduct new project planning, seed technology construction, practical application technological development, commercialization support and consulting services in the biotechnology field.
  • Management
    Tomohiro Fujita Ph.D. / Chief Executive Officer Rie Kugimiya / Chief Operating Officer Masayuki Imai / Chief Financial Officer Takayuki Horiuchi Ph.D. / Chief Technology Officer Naoko Nomoto / Chief Administration & Accounting Officer Sakayu Shimizu Ph.D. / Advisor Mitsuru Furusawa Ph.D. / Chief Scientific Advisor
  • ShareholdersCHITOSE BIO EVOLUTION PTE. LTD.:76.5%
    Individuals and others:23.5%


  • 2004 Started microbial related business in Chitose Laboratory Corp.
    (formerly known as Neo-Morgan Laboratory Inc.) as a new business development.
  • 2009 Dr.Fujita spearheaded MBO(purchase of shares from VC companies) of Chitose Laboratory Corp.
  • 2010 Started the business to manufacture microalgae-based fuel and raw materials.
  • 2011 Started the business to construct a sustainable circular palm plantation in Sandakan, Malaysia.
  • 2011 Established the holding company in Singapore.
  • 2013 Re-named the holding company as CHITOSE BIO EVOLUTION PTE.LTD. and reorganized the whole group as CHITOSE group.
  • 2015 Started agricultural production in Cameron Highlands, Malaysia.
  • 2016 Started the business to analyse the gut and soil microbiomes.
  • 2016 Established super cell CHO-MK for medical purposes.
  • 2018 Started Cell Line Development(CLD) business utilising CH-MK cell line.
  • 2019
    • Started the business to digitalise the bio-production utilising Convolutional data.
  • 2021 Started the MATSURI project to build the microalgae industry.
  • 2023 Founded and started operating 5-hectare microalgae production facility in Malaysia.
    MATSURI selected by the New Energy and Industrial Technology Development Organization(NEDO) for Green Innovation Fund of 400M USD Scale.
    Raised 3.1 billion yen scale from Shiseido Company, Limited, NGK INSULATORS, LTD. etc., a total of 8 companies.
    Chitose Laboratory Corp. has established the Sarawak Branch in Kuching, Malaysia.

Business bases

  • Business bases Kanagawa(Nogawa Laboratory, KSP Laboratory), Singapore, Malaysia(Cameron Highlands, Ipoh, Kuching), Brunei
  • Other bases
    (Our collaborators bases)
    Kyoto, Niigata, Shizuoka, Yamanashi, Kagawa, Saga, Osaka, Malaysia(Kuala Lumpur, Sandakan)

Business Entities

  • Chitose Agri Laboratory Sdn. Bhd.
  • Tabérumo Corporation
  • Chitose Agriculture Initiative Pte. Ltd.
  • Chitose Flora Corp.
  • business entities

Contact Us

  • info@chitose-bio.com